DNA X Announces $8.1M Private Placement Of 1.35M Series B Preferred Shares At $6.00/Share, Including $5M Cash And $3.1M Debt Cancellation
On June 29, 2026, DNA X, Inc. (the "Company") entered into a securities purchase agreement (the "Purchase Agreement") with DNA Holdings Venture, Inc. ("DNA Holdings"), a holder of more than 5% of the Company’s outstanding capital stock and an entity associated with Scott Walker, a member of the Company’s board of direc